The new products are in the areas of gastrointestinal and respiratory medicines More: ALTURiX acquires exclusive UK rights to three new products Source: News
read moreFTC calls for ‘expansive and flexible’ use of march-in rights to rein in drug prices aliu Tue, 02/06/2024 – 16:13 More: FTC calls for 'expansive and flexible' use of march-in rights to rein in drug prices Source: fierce
read moreWith Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices kdunleavy Tue, 02/06/2024 – 15:34 More: With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices Source: fierce
read moreAmid GLP-1 supply constraints, Lilly to prep for oral market ‘at risk’ zbecker Tue, 02/06/2024 – 12:53 More: Amid GLP-1 supply constraints, Lilly to prep for oral market 'at risk' Source: fierce
read moreAs Vertex gears up for next-gen CF treatment, Trikafta sales reach $8.9B thanks to label expansions kdunleavy Tue, 02/06/2024 – 10:45 More: As Vertex gears up for next-gen CF treatment, Trikafta sales reach .9B thanks to label expansions Source: fierce
read moreAlready rolling in diabetes and obesity, Eli Lilly touts tirzepatide’s midstage MASH win aliu Tue, 02/06/2024 – 10:05 More: Already rolling in diabetes and obesity, Eli Lilly touts tirzepatide's midstage MASH win Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals